No difference seen in percentage of patients recovering at each time point for robot-assisted versus open radical cystectomy
THURSDAY, March 3, 2022 (HealthDay News) — Patients require three to six months to recover to baseline levels of independence after radical cystectomy, irrespective of surgical approach, according to a study published online Feb. 16 in JAMA Network Open.
Vivek Venkatramani, M.D., from the University of Miami Miller School of Medicine, and colleagues assessed time to recovery of functional independence after radical cystectomy and whether differences exist between robot-assisted radical cystectomy (RARC) and open procedures. This secondary analysis included data from a randomized clinical trial for 302 patients treated at 15 academic medical centers from July 1, 2011, to Nov. 18, 2014.
The researchers found that overall, activities of daily living (ADL), independent ADL, and the timed up & go walking test (TUGWT) recovered to baseline by three postoperative months, while hand grip strength took six months. For RARC, activities of daily living recovered at one month versus three months after open radical cystectomy (ORC). For hand grip strength, RARC recovery occurred by three months versus six months after ORC. In the RARC group, 35.6 percent of patients showed a recovery in hand grip strength at three months compared with 36.4 percent in the ORC group. Recovery in three months was similar for independent ADL and TUGWT.
“These findings suggest that recovery after radical cystectomy takes three to six months and recovery in some domains may be quicker after RARC,” the authors write.
One author disclosed financial ties to FerGene and UroGen Pharma.
Local Recurrence Rate Low After R0 Resection of Soft Tissue Sarcoma Tumors
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
ASTRO Issues Guidance for Use of Radiation Therapy in Bladder Cancer
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer
Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer